1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow A(2)C: new trials by email Literature Review of A(2)C trials Research Report on A(2)C
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) Bdq(Lzd)+Lfx(Mfx)+Cfz(Cs)+Pto+E+H+Z, A1, A2a - Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis | Phase 3 | Recruiting | Huashan Hospital | 1050 | 2022-05-23 | 2025-04-06 |
Tuberculosis, Multidrug-Resistant (1)
Huashan Hospital (1)
China (1)